DGAP-News: ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
- 66
DGAP-News: ReShape Lifesciences Inc.
/ Key word(s): Merger
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their previously announced merger to be effective after the close of the market today, June 15, 2021. The shares of common stock of the combined company are expected to commence trading on The Nasdaq Capital Market on Wednesday, June 16, 2021, under the name ReShape Lifesciences Inc. and the trading symbol "RSLS." Immediately following the effective time of the merger, existing ReShape stockholders will own 51% and existing Obalon stockholders will own 49% of the outstanding shares of common stock of the combined company. Holders of shares of ReShape common stock will receive 0.5637 shares of the combined company's common stock for each share of ReShape common stock then held (as calculated on a post-reverse stock split basis). Holders of shares of Obalon common stock will continue to hold their shares, subject to adjustment for the reverse stock split of Obalon's common stock prior to the merger. At a special meeting of Obalon's stockholders on May 25, 2021, Obalon's stockholders approved the issuance of shares of Obalon's common stock to the stockholders of ReShape and an amendment to Obalon's certificate of incorporation to effect the reverse stock split. Immediately prior to the closing of the merger, Obalon will effect a 1-for-3 reverse stock split of its common stock. At a special meeting of ReShape's stockholders on May 13, 2021, ReShape's stockholders approved the merger and other transactions contemplated by the agreement and plan of merger. About ReShape Lifesciences Inc. About Obalon Therapeutics, Inc. Forward-Looking Statements ReShape Contact: ReShape Investor Contact: SOURCE: ReShape Lifesciences Inc.
15.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
1208349 15.06.2021
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.
- Man Group PLC : Form 8.3 - Barratt Developments plc
- Man Group PLC : Form 8.3 - Tyman plc
- Global Sources Mobile Electronics Exhibitions, Emdoor Digital Showcases New Technology Trends
- Capital Gearing Trust Plc - Quarterly Report
- Autohome Inc. to Announce First Quarter 2024 Financial Results on May 8, 2024
- ACEM Shines in 2024 QS World University Rankings by Subject, Three disciplines ranked among the top 50